Which test helps differentiate a factor deficiency from a factor inhibitor in hemophilia patients?

Which test helps differentiate a factor deficiency from a factor inhibitor in hemophilia patients?

• A. Mixing studies
• B. PT
• C. Platelet count
• D. Bleeding time

Answer: (A)

A mixing study tests whether a prolonged clotting time is due to a missing factor or an antibody that inhibits the factor. When patient plasma is mixed with normal plasma, if the intrinsic pathway abnormality corrects, it means the patient is deficient in a clotting factor that the normal plasma supplies. If the prolonged time persists (and especially if it worsens after incubation), it points to the presence of an inhibitor that neutralizes the factor even in the mixed plasma. This distinction is crucial because a deficiency is treated by replacing the missing factor, whereas an inhibitor requires different strategies and specific testing (like a Bethesda assay) to quantify and manage the inhibitor. PT, platelet count, and bleeding time assess other aspects of coagulation or platelet function and do not differentiate between deficiency and inhibitor in the same way.

A mixing study tests whether a prolonged clotting time is due to a missing factor or an antibody that inhibits the factor. When patient plasma is mixed with normal plasma, if the intrinsic pathway abnormality corrects, it means the patient is deficient in a clotting factor that the normal plasma supplies. If the prolonged time persists (and especially if it worsens after incubation), it points to the presence of an inhibitor that neutralizes the factor even in the mixed plasma. This distinction is crucial because a deficiency is treated by replacing the missing factor, whereas an inhibitor requires different strategies and specific testing (like a Bethesda assay) to quantify and manage the inhibitor. PT, platelet count, and bleeding time assess other aspects of coagulation or platelet function and do not differentiate between deficiency and inhibitor in the same way.